A pre-blended GHRH-analog plus selective ghrelin-receptor agonist. Co-lyophilized for synergistic-pulse GH-axis research protocols.
Purity (HPLC)
≥ 99.34%
Net peptide
5.00 mg ± 2%
Endotoxin
< 0.5 EU/mg
Format
Lyophilized vial
Storage
−20 °C, desiccated
Shelf life
24 months from MFG
$95CAD/ 10 mg vial
In stock · Lot LM-2615
Qty
Add $300 for Free shipping
HPLC + MS verified per lot
~4 days to your door
COA bundled with shipment
Lot samples retained 5 years
Overview
CJC-1295 / Ipamorelin pairs a 30-residue GHRH(1-29) analog with a 5-residue selective growth-hormone secretagogue (ghrelin-receptor agonist). The two mechanisms are studied in parallel for synergistic pulsatile GH release in cell-culture and rodent models.
Each component meets ≥ 99% HPLC purity independently before co-lyophilization. Vials are sealed under nitrogen and shipped ~4 days from our lab.
Research applications
Synergistic GHRH-R + GHS-R activation studies, pituitary GH-secretion potentiation assays, and comparative pulsatile-release pharmacokinetics versus CJC-1295 or Ipamorelin alone.
Sold for laboratory research only. This material is not a drug, food, or cosmetic and is not intended for diagnostic, therapeutic, or recreational use.
Identity
Parameter
Value
Sequence
CJC-1295 (no DAC) + Ipamorelin
Molecular formula
Pre-blend
Molecular weight
Mixed (3367.93 + 711.86 g/mol)
CAS number
Mixed (863288-34-0 / 170851-70-4)
Length
Pre-blend (30 + 5 residues)
Quality
Test
Specification
HPLC purity
≥ 99.0% per component (HPLC, on receipt)
Mass confirmation
ESI-MS within 0.5 Da
Net peptide content
≥ 80% by AAA
Endotoxin
< 0.5 EU/mg (LAL)
Bioburden
< 10 CFU/g
Residual TFA
< 1.0%
Lot LM-2615
Manufactured 04 Mar 2026 · Released 11 Mar 2026 · Tested by Lumera QC, Canada. Retain samples held under storage spec for five years from release date.
Verification
Method
Result
RP-HPLC at 220 nm
≥ 99.0% per component main peak
ESI-MS (positive)
Two peaks: 3367.9 + 711.9 Da
Amino acid analysis
82.1% net peptide
LAL endotoxin
< 0.05 EU/mg
Karl Fischer (water)
2.8% w/w
Reconstitution
Allow vial to reach room temperature before opening (≥ 20 minutes). Reconstitute with 1.0–2.5 mL of sterile bacteriostatic water (0.9% benzyl alcohol). Inject solvent slowly down the inner wall of the vial; do not direct stream onto the lyophilized cake.
Swirl gently for 30 seconds. Do not vortex. Allow to dissolve for 5 minutes; clarity should be complete with no visible particulates.
Storage after reconstitution
Reconstituted solution is stable for 28 days at 2–8 °C in original vial. For longer storage, aliquot into low-binding tubes and hold at −80 °C; avoid repeated freeze-thaw cycles. Discard if turbidity, color change, or particulate matter is observed.
Selected references
Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552–561.
Teichman SL et al. Prolonged stimulation of GH/IGF-I by CJC-1295. J Clin Endocrinol Metab. 2006;91(3):799–805.
